Comprehensive characterization of somatic variants associated with intronic polyadenylation in human cancers

Zhaozhao Zhao1, Qiushi Xu1, Ran Wei1,2

  • 1State Key Laboratory of Genetic Engineering, Collaborative Innovation Center of Genetics and Development, Human Phenome Institute, School of Life Sciences and Huashan Hospital, Fudan University, Shanghai 200438, P.R. China.

Nucleic Acids Research
|September 11, 2021
PubMed

Insights

Somatic single nucleotide variants (SNVs) near splice sites can cause abnormal intronic polyadenylation (IPA), a novel mechanism affecting gene expression in cancer. This finding impacts understanding of cancer-related gene mutations and their functional consequences.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Somatic single nucleotide variants (SNVs) in cancer genomes can alter gene expression.
  • While SNVs near splice sites are known to cause abnormal splicing, other mechanisms remain unexplored.

Purpose of the Study:

  • To investigate novel mechanisms by which somatic SNVs affect gene expression in cancer.
  • To identify and characterize SNVs associated with abnormal intronic polyadenylation (IPA).

Main Methods:

  • Analysis of RNA sequencing and exome data from 4,998 cancer patients across ten cancer types.
  • Identification of somatic SNVs near splice sites associated with IPA.
  • Minigene assays to validate the functional impact of SNVs on IPA.

Main Results:

  • 152 somatic SNVs associated with IPA were identified, predominantly near donor splice sites.
  • IPA-associated SNVs were enriched in tumor suppressor genes (TSGs) like PTEN and CDH1.
  • Genomic features like GC content and intron length differentiated IPA from intron retention.

Conclusions:

  • Abnormal intronic polyadenylation (IPA) is a novel mechanism through which somatic SNVs impact gene expression in human cancers.
  • Understanding SNV-associated IPA provides new insights into cancer development and potential therapeutic targets.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.1K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
22.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.2K